Home E-Weekly September 12, 2017

Disappointing Results for Laparoscopic Anti-GERD Surgery

Published: September 11, 2017

UPSETTING RESULT Women were especially vulnerable to recurrent symptoms after laparoscopic anti-reflux surgery.

Laparoscopic anti-reflux surgery failed to produce the desired results in about 1 in 6 patients, a new large-scale study has found.

The retrospective study, which was published in the Journal of the American Medical Association, found that among 2,655 adult patients who had anti-reflux surgery in Sweden between 2005 and 2014, about 18% continued to use anti-GERD medication (proton pump inhibitors or histamine H2-receptor antagonists) for more than 6 months after surgery (84%) or had secondary anti-reflux surgeries (16%).

The study didn't distinguish between patients who'd undergone total or partial fundoplication, or some other anti-reflux procedure.

Women were more likely to be vulnerable to continued GERD symptoms after surgery (22% vs. 14% of men), and older age and comorbidities were also risk factors.

The "relatively high rate of recurrent GERD requiring long-term treatment, diminish[es] some of the benefits of the operation," the authors write.

Jim Burger

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Large Polyps Not as Big a Cancer Risk as Previously Thought

Special Report From DDW: 7 Cool New Gadgets Your GI Docs Will Love

A gastroenterologist tours Digestive Disease Week's exhibit hall.

3 GI Trends Worth Watching

A new way to prep (make that cleanse), better adenoma detection and advances in the treatment of reflux disease.